GENEXTRA S.P.A. REPORTS 5.89% PASSIVE STAKE IN QUINCE THERAPEUTICS
Total Cash (mrq) 83.22M Total Cash Per Share (mrq) 1.94 Total Debt (mrq) 61k Book Value Per Share (mrq) 2.29 Shares Outstanding 42.87M Float 31.07M Shares Short (prior month Oct 30, 2023) 4 2.16M
We see more and more big shareholders, I think we will see 1.50 – 1.75 this week.
Well-capitalized into 2026 with ability to fully fund lead asset EryDex expected through Phase 3 trial under special protocol assessment (SPA) and to NDA submission
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.